Nanoscale mapping and organization analysis of target proteins on cancer cells from B-cell lymphoma patients

Experimental Cell Research

Volumn 319, Issue 18, 2013, Pages 2812-2821

  Li, Mi ^a,b   Xiao, Xiubin ^c   Liu, Lianqing ^a   Xi, Ning ^a,d   Wang, Yuechao ^a   Dong, Zaili ^a   Zhang, Weijing ^c  

^a SHENYANG INSTITUTE OF AUTOMATION   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atomic force microscopy; Cancer cell; CD20; Non Hodgkin's lymphoma; Rituximab; ROR1

Indexed keywords

CD20 ANTIGEN; FLUORESCENT DYE; RITUXIMAB;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; B CELL LYMPHOMA; CELL SIZE; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

EID: 84886255045     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.07.020     Document Type: Article

References (57)

1. Deans J.P., Li H., Polyak M.J. CD20-mediated apoptosis: signaling through lipid rafts. Immunology 2002, 107:176-182.
2. Boross P., Leusen J.H.W. Mechanisms of action of CD20 antibodies. Am. J. Cancer Res 2012, 2:676-690.
3. Cragg M.S., Walshe C.A., Ivanov A.O., Glennie M.J. The biology of CD20 and its potential as a target for mAb therapy. Curr. Dir. Autoimmun 2005, 8:140-174.
4. Perosa F., Prete M., Racanelli V., Dammacco F. CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. J. Intern. Med. 2010, 267:260-277.
5. Beers S.A., Chan C.H.T., French R.R., Cragg M.S., Glennie M.J. CD20 as a target for therapeutic type I and II monoclonal antibodies. Semin. Hematol. 2010, 47:107-114.
6. Glennie M.J., French R.R., Cragg M.S., Taylor R.P. Mechanisms of killing by anti-CD20 monoclonal antibodies. Mol. Immunol. 2007, 44:3823-3837.
7. Cheson B.D., Leonard J.P. Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. N. Engl. J. Med. 2008, 359:613-626.
8. Alduaij W., Illidge T.M. The future of anti-CD20 monoclonal antibodies: are we making progress. Blood 2011, 117:2993-3001.
9. Oflazoglu E., Audoly L.P. Evolution of anti-CD20 monoclonal antibody therapeutics in oncology. mAbs 2010, 2:14-19.
10. Lim S.H., Beers S.A., French R.R., Johnson P.W.M., Glennie M.J., Cragg M.S. Anti-CD20 monoclonal antibodies: historical and future perspectives. Haematologica 2010, 95:135-143.
11. Racila E., Link B.K., Weng W.K., Witzig T.E., Ansell S., Maurer M.J., Huang J., Dahle C., Halwani A., Levy R., Weiner G.J. A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma. Clin. Cancer Res. 2008, 14:6697-6703.
12. Weiner G.J. Rituximab: mechanism of action. Semin. Hematol. 2010, 47:115-123.
13. Marcucci F., Bellone M., Rumio C., Corti A. Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells. mAbs 2013, 5:34-46.
14. Maloney D.G. Anti-CD20 antibody therapy for B-cell lymphomas. N. Engl. J. Med. 2012, 366:2008-2016.
15. Humburg M.A., Collins F.S. The path to personalized medicine. N. Engl. J. Med. 2010, 363:301-304.
16. Offit K. Personalized medicine: new genomics, old lessons. Hum. Genet. 2011, 130:3-14.
17. Li G.W., Xie X.S. Central dogma at the single-molecule level in living cells. Nature 2011, 475:308-315.
18. Muller D.J., Dufrene Y.F. Atomic force microscopy: a nanoscopic window on the cell surface. Trends Cell Biol. 2011, 21:461-469.
19. Muller D.J., Helenius J., Alsteens D., Dufrene Y.F. Force probing surfaces of living cells to molecular resolution. Nat. Chem. Biol. 2009, 5:383-390.
20. Dufrene Y.F., Evans E., Engel A., Helenius J., Gaub H.E., Muller D.J. Five challenges to bringing single-molecule force spectroscopy into living cells. Nat. Methods 2011, 8:123-127.
21. Carvalho F.A., Santos N.C. Atomic force microscopy-based force spectroscopy-biological and biomedical applications. IUBMB Life 2012, 64:465-472.
22. Shi X., Zhang X., Xia T., Fang X. Living cell study at the single-molecule and single-cell levels by atomic force microscopy. Nanomedicine 2012, 7:1625-1637.
23. Hudecek M., Schmitt T.M., Baskar S., Lupo-Stanghellini M.T., Nishida T., Yamamoto T.N., Bleakley M., Turtle C.J., Chang W.C., Greisman H.A., Wood B., Maloney D.G., Jensen M.C., Rader C., Riddell S.R. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. Blood 2010, 116:4532-4541.
24. Baskar S., Kwong K., Hofer T., Levy J.M., Kennedy M.G., Lee E., Staudt L.M., Wilson W.H., Wiestner A., Rader C. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clin. Cancer Res. 2008, 14:396-404.
25. T. Fukuda, L. Chen, T. Endo, L. Tang, D. Lu, J. E. Castro, G. F. Widhopf, L. Z. Rassenti, M. J. Cantwell, C. E. Prussak, D. A. Carson, T. J. Kipps, Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a, Proc. Natl. Acad. Sci. USA 105 (2008) 3047-3052.
26. Uhrmacher S., Schmidt C., Erdfelder F., Poll-Wolbeck S.J., Gehrke I., Hallek M., Kreuzer K.A. Use of the receptor tyrosine kinase-orphan receptor 1[ROR1] as a diagnostic tool in chronic lymphocytic leukemia[CLL]. Leuk. Res. 2011, 35:1360-1366.
27. Barna G., Mihalik R., Timar B., Tombol J., Csende Z., Sebestyen A., Bodor C., Csernus B., Reiniger L., Petak I., Matolcsy A. ROR1 expression is not a unique marker of CLL. Hematol. Oncol. 2011, 29:17-21.
28. Hinderdorfer P., Dufrene Y.F. Detection and localization of single molecular recognition events using atomic force microscopy. Nat. Methods 2006, 3:347-355.
29. Li M., Xiao X., Liu L., Xi N., Wang Y., Dong Z., Zhang W. Atomic force microscopy study of the antigen-antibody binding force on patient cancer cells based on ROR1 fluorescence recognition. J. Mol. Recognition 2013, 26:432-438.
30. Li M., Xiao X., Liu L., Xi N., Wang Y., Dong Z., Zhang W. Imaging and measuring the molecular force of lymphoma pathological cells using atomic force microscopy. Scanning 2013, 35:40-46.
31. Hutter J.L., Bechhoefer J. Calibration of atomic-force microscope tips. Rev. Sci. Instrum 1993, 64:1868-1873.
32. Lebien T.W., Tedder T.F. B lymphocyte: how they develop and function. Blood 2008, 112:1570-1579.
33. Mauri C., Bosma A. Immune regulatory function of B cells. Ann. Rev. Immunol 2012, 30:221-241.
34. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
35. Lee C.K., Wang Y.M., Huang L.S., Lin S. Atomic force microscopy: determining of unbinding force, off rate and energy barrier for protein-ligand interaction. Micron 2007, 38:446-461.
36. Wildling L., Rankl C., Haselgrubler T., Gruber H.J., Holy M., Newman A.H., Zou M.F., Zhu R., Freissmuth M., Sitte H.H., Hinterdorfer P. Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells. J. Biol. Chem. 2012, 287:105-113.
37. Tripathi P., Beaussart A., Alsteens D., Dupres V., Claes I., Ossowski I.V., Vos W.M.D., Palva A., Lebeer S., Vanderleyden J., Dufrene Y.F. Adhesion and nanomechanics of pili from the probiotic lactobacillus rhamnosus GG. ACS Nano 2013, 7:3685-3697.
38. Sanchez S.A., Tricerri M.A., Gratton E. Laurdan generalized polarization fluctuations measures membrane packing micro-heterogeneity in vivo. Proc. Natl. Acad. Sci. USA 2012, 109:7314-7319.
39. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
40. Casuso I., Khao J., Chami M., Paul-Gilloteaux P., Husain M., Duneau J.P., Stahlberg H., Sturgis J.N., Scheuring S. Characterization of the motion of membrane proteins using high-speed atomic force microscopy. Nat. Nanotechnol 2012, 7:525-529.
41. McMahon H.T., Gallop J.L. Membrane curvature and mechanisms of dynamic cell membrane remodeling. Nature 2005, 438:590-596.
42. Huh Y.O., Keating M.J., Saffer H.L., Jilani I., Lerner S., Albitar M. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia. Am. J. Clin. Pathol. 2001, 116:437-443.
43. Johnson N.A., Boyle M., Bashashati A., Leach S., Brooks-Wilson A., Sehn L.H., Chhanabhai M., Brinkman R.R., Connors J.M., Weng A.P., Gascoyne R.D. Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival. Blood 2009, 113:3773-3780.
44. Oesterhelt F., Oesterhelt D., Pfeiffer M., Engel A., Gaub H.E., Muller D.J. Unfolding pathways of individual bacteriorhodopsins. Science 2000, 288:143-146.
45. Ando T., Uchihashi T., Kodera N. High-speed AFM and applications to biomolecular systems. Annu. Rev. Biophys 2013, 42:393-414.
46. Dupres V., Menozzi F.D., Locht C., Clare B.H., Abbott N.L., Cuenot S., Bompard C., Raze D., Dufrene Y.F. Nanoscale mapping and functional analysis of individual adhesions on living bacteria. Nat. Methods 2005, 2:515-520.
47. Alsteens D., Garcia M.C., Lipke P.N., Dufrene Y.F. Force-induced formation and propagation of adhesion nanodomains in living fungal cells. Proc. Natl. Acad. Sci. USA 2010, 107:20744-20749.
48. Alsteens D., Dupres V., Yunus S., Latge J.P., Heinisch J.J., Dufrene Y.F. High-resolution imaging of chemical and biological sites on living cells using peak force tapping atomic force microscopy. Langmuir 2012, 28:16738-16744.
49. + T cell membrane. J. Mol. Recognition 2009, 22:516-520.
50. Soumetz F.C., Saenz J.F., Pastorino L., Ruggiero C., Nosi D., Raiteri R. Investigation of integrin expression on the surface of osteoblast-like cells by atomic force microscopy. Ultramicroscopy 2010, 110:330-338.
51. Lama G., Papi M., Angelucci C., Maulucci G., Sica G., Spirito M.D. Leuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interaction. Plos One 2013, 8:e52530.
52. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610.
53. Plodinec M., Loparic M., Monnier C.A., Obermann E.C., Zanetti-Dallenbach R., Oertle P., Hyotyla J.T., Aebi U., Bentires-Alj M., Lim R.Y.H., Schoenenberger C.A. The nanomechanical signature of breast cancer. Nat. Nanotechnol 2012, 7:757-765.
54. Lekka M., Gil D., Pogoda K., Dulinska-Litewka J., Jach R., Gostek J., Klymenko O., Prauzner-Bechcicki S., Stachura Z., Wiltowska-Zuber J., Okon K., Laidler P. Cancer cell detection in tissue sections using AFM. Arch. Biochem. Biophys. 2012, 518:151-156.
55. Sawyers C.L. The cancer biomarker problem. Nature 2008, 452:548-552.
56. Weiner L.M., Murray J.C., Shuprine C.W. Antibody-based immunotherapy of cancer. Cell 2012, 148:1081-1084.
57. Chan A.C., Carter P.J. Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. Immunol. 2010, 10:301-316.